These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19388456)

  • 1. [Calcium antagonists--how does Furberg see them now?].
    Nilsson PM
    Lakartidningen; 2009 Feb 25-Mar 3; 106(9):607-8; author reply 608. PubMed ID: 19388456
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 3. [No bluff to be discovered in clinical trials].
    Berglund T
    Lakartidningen; 2009 Mar 25-31; 106(13):952-3. PubMed ID: 19441200
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflict of interest in the debate over calcium-channel antagonists.
    Meltzer JI
    N Engl J Med; 1998 Jun; 338(23):1696; author reply 1697-8. PubMed ID: 9616063
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflict of interest in the debate over calcium-channel antagonists.
    Strandgaard S
    N Engl J Med; 1998 Jun; 338(23):1697-8. PubMed ID: 9616065
    [No Abstract]   [Full Text] [Related]  

  • 6. Stopping medical research to save money: a broken pact with researchers and patients.
    Psaty BM; Rennie D
    JAMA; 2003 Apr 23-30; 289(16):2128-31. PubMed ID: 12709471
    [No Abstract]   [Full Text] [Related]  

  • 7. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 8. [The "Furberg bias" or: about the arbitrary handling of evidence-based medicine].
    Middeke M
    Dtsch Med Wochenschr; 2001 Feb; 126(6):151-2. PubMed ID: 11233884
    [No Abstract]   [Full Text] [Related]  

  • 9. Conflict of interest in the debate over calcium-channel antagonists.
    Opie L
    N Engl J Med; 1998 Jun; 338(23):1696-7; author reply 1697-8. PubMed ID: 9616064
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stated conflict of interest].
    Reseland S
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2408; author reply 2408. PubMed ID: 16998560
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflict of interest in the debate over calcium-channel antagonists.
    Stelfox HT; Chua G; O'Rourke K; Detsky AS
    N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSJAMA: Industry funding of clinical trials: benefit or bias?
    Chopra SS
    JAMA; 2003 Jul; 290(1):113-4. PubMed ID: 12837722
    [No Abstract]   [Full Text] [Related]  

  • 14. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O
    BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014
    [No Abstract]   [Full Text] [Related]  

  • 15. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of interest in clinical research: addressing the issue of physician remuneration.
    Caulfield T; Griener G
    J Law Med Ethics; 2002; 30(2):305-8. PubMed ID: 12066609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dishonesty in clinical trials is expensive for the society 1].
    Heslet L; Nielsen JD; Schierbeck J
    Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dishonesty in clinical trials is expensive for the society 2].
    Lund BA; Nordby G
    Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dishonesty in clinical trials is expensive for the society 3].
    Waldorff S
    Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
    [No Abstract]   [Full Text] [Related]  

  • 20. Is academic medicine for sale?
    Firlik AD; Lowry DW
    N Engl J Med; 2000 Aug; 343(7):509-10. PubMed ID: 10950674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.